Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3270617, 6 pages
https://doi.org/10.1155/2017/3270617
Research Article

Cardiovascular Autonomic Neuropathy Is an Independent Risk Factor for Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes

1Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, Jiangsu, China
2Department of Endocrinology, Drum Tower Clinical Medical College, Nanjing Medical University, Jiangsu, China

Correspondence should be addressed to Dalong Zhu; nc.ude.ujn@gnoladuhz

Received 15 February 2017; Accepted 9 May 2017; Published 30 May 2017

Academic Editor: Michael Gotzmann

Copyright © 2017 Jiewen Jin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Spallone, D. Ziegler, R. Freeman et al., “Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management,” Diabetes Metabolism Research and Reviews, vol. 27, no. 7, pp. 639–653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Ziegler, “Diabetic cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment,” Diabetes Metabolism Reviews, vol. 10, no. 4, pp. 339–383, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. U. M. Mogensen, T. Jensen, L. Køber et al., “Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients,” Diabetes, vol. 61, no. 7, pp. 1822–1830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Ziegler, A. F. Gries, and H. Muhlen, “Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group,” Diabete Metab, vol. 19, no. 1 Pt 2, pp. 143–151, 1993. View at Google Scholar
  5. R. Pop-Busui, P. A. Low, B. H. Waberski et al., “Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the diabetes control and complications trial/epidemiology of diabetes interventions and complications study (DCCT/EDIC),” Circulation, vol. 119, no. 22, pp. 2886–2893, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. I. Vinik and D. Ziegler, “Diabetic cardiovascular autonomic neuropathy,” Circulation, vol. 115, no. 3, pp. 387–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. E. Maser, B. D. Mitchell, A. I. Vinik, and R. Freeman, “The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes a meta-analysis,” Diabetes Care, vol. 26, no. 6, pp. 1895–1901, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Pop-Busui, G. W. Evans, H. C. Gerstein et al., “Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial,” Diabetes Care, vol. 33, no. 7, pp. 1578–1584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. Soedamah-Muthu, N. Chaturvedi, D. R. Witte, L. K. Stevens, M. Porta, and J. H. Fuller, “Relationship between risk factors and mortality in type 1 diabetic patients in europe: The eurodiab prospective complications study (PCS),” Diabetes Care, vol. 31, no. 7, pp. 1360–1366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. I. Vinik, R. Freeman, and T. Erbas, “Diabetic autonomic neuropathy,” Seminars in Neurology, vol. 23, no. 4, pp. 365–372, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Rossing, L. Breum, A. Major-Pedersen et al., “Prolonged QTc interval predicts mortality in patients with type 1 diabetes mellitus,” Diabetic Medicine, vol. 18, no. 3, pp. 199–205, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. D. S. H. Bell, “Heart failure: the frequent, forgotten, and often fatal complication of diabetes,” Diabetes Care, vol. 26, no. 8, pp. 2433–2441, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. R. S. Bhatia, J. V. Tu, D. S. Lee et al., “Outcome of heart failure with preserved ejection fraction in a population-based study,” The New England Journal of Medicine, vol. 355, no. 3, pp. 260–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Poanta, M. Porojan, and D. L. Dumitrascu, “Heart rate variability and diastolic dysfunction in patients with type 2 diabetes mellitus,” Acta Diabetologica, vol. 48, no. 3, pp. 191–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Pop-Busui, P. A. Cleary, B. H. Braffett et al., “Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (diabetes control and complications trial/epidemiology of diabetes interventions and complications),” Journal of the American College of Cardiology, vol. 61, no. 4, pp. 447–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. Sacre, B. Franjic, C. L. Jellis, C. Jenkins, J. S. Coombes, and T. H. Marwick, “Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes,” JACC: Cardiovascular Imaging, vol. 3, no. 12, pp. 1207–1215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Novak, “Quantitative autonomic testing,” Journal of Visualized Experiments, no. 53, Article ID e2502, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Mythri and H. Rajeev, “Left ventricular diastolic dysfunction (LVDD) & cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (DM): a cross-sectional clinical study,” Journal of Clinical and Diagnostic Research, vol. 9, no. 1, pp. OC18–OC22, 2015. View at Google Scholar
  19. R. Mogelvang, P. Sogaard, S. A. Pedersen et al., “Cardiac dysfunction assessed by echocardiographic tissue doppler imaging is an independent predictor of mortality in the general population,” Circulation, vol. 119, no. 20, pp. 2679–2685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. F. Nagueh, C. P. Appleton, T. C. Gillebert et al., “Recommendations for the evaluation of left ventricular diastolic function by echocardiography,” European Journal of Echocardiography, vol. 10, no. 2, pp. 165–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. H. Wan, M. W. Vogel, and H. H. Chen, “Pre-clinical diastolic dysfunction,” Journal of the American College of Cardiology, vol. 63, no. 5, pp. 407–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. K. Poulsen, J. E. Henriksen, J. Dahl et al., “Left ventricular diastolic function in type 2 diabetes mellitus prevalence and association with myocardial and vascular disease,” Circulation Cardiovascular Imaging, vol. 3, no. 1, pp. 24–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. H. Imam, C. K. Karmakar, H. F. Jelinek, M. Palaniswami, and A. H. Khandoker, “Analyzing systolic-diastolic interval interaction characteristics in diabetic cardiac autonomic neuropathy progression,” IEEE Journal of Translational Engineering in Health and Medicine, vol. 3, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Habek, N. Lakusic, P. Kruzliak, J. Sikic, D. Mahovic, and L. Vrbanic, “Left ventricular diastolic function in diabetes mellitus type 2 patients: correlation with heart rate and its variability,” Acta Diabetologica, vol. 51, no. 6, pp. 999–1005, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Dinh, R. Futh, M. Lankisch et al., “Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with type 2 diabetes and impaired glucose tolerance undergoing coronary angiography,” Diabetic Medicine, vol. 28, no. 3, pp. 311–318, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Pappachan, J. Sebastian, B. C. Bino et al., “Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis,” Postgraduate Medical Journal, vol. 84, no. 990, pp. 205–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. H. Khandoker, M. H. Imam, J.-P. Couderc, M. Palaniswami, and H. F. Jelinek, “QT variability index changes with severity of cardiovascular autonomic neuropathy,” IEEE Transactions on Information Technology in Biomedicine, vol. 16, no. 5, pp. 900–906, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. C. de Bruyne, A. W. Hoes, J. A. Kors et al., “Prolonged QT interval predicts cardiac and all-cause mortality in the elderly,” European Heart Journal, vol. 20, no. 4, pp. 278–284, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. M. T. Schram, P. J. Kostense, R. A. Van Dijk et al., “Diabetes, pulse pressure and cardiovascular mortality: the hoorn study,” Journal of Hypertension, vol. 20, no. 9, pp. 1743–1751, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Philips, M. Marchand, and A. J. Scheen, “Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes,” Diabetes Metabolism Research and Reviews, vol. 25, no. 5, pp. 442–451, 2009. View at Publisher · View at Google Scholar · View at Scopus